These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


199 related items for PubMed ID: 21763340

  • 1. The smoking cessation drug varenicline improves deficient P20-N40 inhibition in DBA/2 mice.
    Wildeboer-Andrud KM, Stevens KE.
    Pharmacol Biochem Behav; 2011 Nov; 100(1):17-24. PubMed ID: 21763340
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Varenicline blocks β2*-nAChR-mediated response and activates β4*-nAChR-mediated responses in mice in vivo.
    Ortiz NC, O'Neill HC, Marks MJ, Grady SR.
    Nicotine Tob Res; 2012 Jun; 14(6):711-9. PubMed ID: 22241831
    [Abstract] [Full Text] [Related]

  • 7. Electrophysiological perspectives on the therapeutic use of nicotinic acetylcholine receptor partial agonists.
    Papke RL, Trocmé-Thibierge C, Guendisch D, Al Rubaiy SA, Bloom SA.
    J Pharmacol Exp Ther; 2011 May; 337(2):367-79. PubMed ID: 21285282
    [Abstract] [Full Text] [Related]

  • 8. Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of alpha4beta2 nicotinic receptors in rats.
    Spiller K, Xi ZX, Li X, Ashby CR, Callahan PM, Tehim A, Gardner EL.
    Neuropharmacology; 2009 Jul; 57(1):60-6. PubMed ID: 19393252
    [Abstract] [Full Text] [Related]

  • 9. The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data.
    Rollema H, Hurst RS.
    Psychopharmacology (Berl); 2018 Sep; 235(9):2479-2505. PubMed ID: 29980822
    [Abstract] [Full Text] [Related]

  • 10. Effects of the novel α7 nicotinic acetylcholine receptor agonist ABT-107 on sensory gating in DBA/2 mice: pharmacodynamic characterization.
    Radek RJ, Robb HM, Stevens KE, Gopalakrishnan M, Bitner RS.
    J Pharmacol Exp Ther; 2012 Dec; 343(3):736-45. PubMed ID: 22988063
    [Abstract] [Full Text] [Related]

  • 11. Olanzapine improves deficient sensory inhibition in DBA/2 mice.
    Simosky JK, Freedman R, Stevens KE.
    Brain Res; 2008 Oct 03; 1233():129-36. PubMed ID: 18687314
    [Abstract] [Full Text] [Related]

  • 12. The contribution of α4β2 and non-α4β2 nicotinic acetylcholine receptors to the discriminative stimulus effects of nicotine and varenicline in mice.
    de Moura FB, McMahon LR.
    Psychopharmacology (Berl); 2017 Mar 03; 234(5):781-792. PubMed ID: 28028600
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Tropisetron improves deficient inhibitory auditory processing in DBA/2 mice: role of alpha 7 nicotinic acetylcholine receptors.
    Hashimoto K, Iyo M, Freedman R, Stevens KE.
    Psychopharmacology (Berl); 2005 Nov 03; 183(1):13-9. PubMed ID: 16136299
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.
    Rollema H, Chambers LK, Coe JW, Glowa J, Hurst RS, Lebel LA, Lu Y, Mansbach RS, Mather RJ, Rovetti CC, Sands SB, Schaeffer E, Schulz DW, Tingley FD, Williams KE.
    Neuropharmacology; 2007 Mar 03; 52(3):985-94. PubMed ID: 17157884
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.